Proteomic	proteomic	O	O
analysis	analysis	O	O
of	of	O	O
striatal	striatal	O	S_disease
proteins	proteins	O	O
in	in	O	O
the	the	O	O
rat	rat	O	O
model	model	O	O
of	of	O	O
L-DOPA-induced	l-dopa-induced	O	O
dyskinesia	dyskinesia	O	S_disease
.	.	O	O

L-DOPA-induced	l-dopa-induced	O	O
dyskinesia	dyskinesia	O	S_disease
(	(	O	O
LID	lid	O	S_disease
)	)	O	O
is	is	O	O
among	among	O	O
the	the	O	O
motor	motor	O	B_disease
complications	complications	O	I_disease
that	that	O	O
arise	arise	O	O
in	in	O	O
Parkinson	parkinson	O	B_disease
's	's	O	I_disease
disease	disease	O	I_disease
(	(	O	O
PD	pd	O	S_disease
)	)	O	O
patients	patients	O	O
after	after	O	O
a	a	O	O
prolonged	prolonged	O	O
treatment	treatment	O	O
with	with	O	O
L-DOPA	l-dopa	O	O
.	.	O	O

To	to	O	O
this	this	O	O
day	day	O	O
,	,	O	O
transcriptome	transcriptome	O	O
analysis	analysis	O	O
has	has	O	O
been	been	O	O
performed	performed	O	O
in	in	O	O
a	a	O	O
rat	rat	O	O
model	model	O	O
of	of	O	O
LID	lid	O	S_disease
[	[	O	O
Neurobiol	neurobiol	O	O
.	.	O	O
Dis	dis	O	O
.	.	O	O
,	,	O	O
17	17	O	O
(	(	O	O
2004	2004	O	O
)	)	O	O
,	,	O	O
219	219	O	O
]	]	O	O
but	but	O	O
information	information	O	O
regarding	regarding	O	O
the	the	O	O
proteome	proteome	O	O
is	is	O	O
still	still	O	O
lacking	lacking	O	O
.	.	O	O

In	in	O	O
the	the	O	O
present	present	O	O
study	study	O	O
,	,	O	O
we	we	O	O
investigated	investigated	O	O
the	the	O	O
changes	changes	O	O
occurring	occurring	O	O
at	at	O	O
the	the	O	O
protein	protein	O	O
level	level	O	O
in	in	O	O
striatal	striatal	O	S_disease
samples	samples	O	O
obtained	obtained	O	O
from	from	O	O
the	the	O	O
unilaterally	unilaterally	O	O
6-hydroxydopamine-lesion	6-hydroxydopamine-lesion	O	O
rat	rat	O	O
model	model	O	O
of	of	O	O
PD	pd	O	S_disease
treated	treated	O	O
with	with	O	O
saline	saline	O	O
,	,	O	O
L-DOPA	l-dopa	O	O
or	or	O	O
bromocriptine	bromocriptine	S_chemical	O
using	using	O	O
two-dimensional	two-dimensional	O	O
difference	difference	O	O
gel	gel	O	O
electrophoresis	electrophoresis	O	O
and	and	O	O
mass	mass	O	O
spectrometry	spectrometry	O	O
(	(	O	O
MS	ms	O	S_disease
)	)	O	O
.	.	O	O

Rats	rats	O	O
treated	treated	O	O
with	with	O	O
L-DOPA	l-dopa	O	O
were	were	O	O
allocated	allocated	O	O
to	to	O	O
two	two	O	O
groups	groups	O	O
based	based	O	O
on	on	O	O
the	the	O	O
presence	presence	O	O
or	or	O	O
absence	absence	O	O
of	of	O	O
LID	lid	O	S_disease
.	.	O	O

Among	among	O	O
the	the	O	O
2000	2000	O	O
spots	spots	O	O
compared	compared	O	O
for	for	O	O
statistical	statistical	O	O
difference	difference	O	O
,	,	O	O
67	67	O	O
spots	spots	O	O
were	were	O	O
significantly	significantly	O	O
changed	changed	O	O
in	in	O	O
abundance	abundance	O	O
and	and	O	O
identified	identified	O	O
using	using	O	O
matrix-assisted	matrix-assisted	O	O
laser	laser	O	O
desorption/ionization	desorption/ionization	O	O
time-of-flight	time-of-flight	O	O
MS	ms	O	S_disease
,	,	O	O
atmospheric	atmospheric	O	O
pressure	pressure	O	O
matrix-assisted	matrix-assisted	O	O
laser	laser	O	O
desorption/ionization	desorption/ionization	O	O
and	and	O	O
HPLC	hplc	O	O
coupled	coupled	O	O
tandem	tandem	O	O
MS	ms	O	S_disease
(	(	O	O
LC/MS/MS	lc/ms/ms	O	O
)	)	O	O
.	.	O	O

Out	out	O	O
of	of	O	O
these	these	O	O
67	67	O	O
proteins	proteins	O	O
,	,	O	O
LID	lid	O	S_disease
significantly	significantly	O	O
changed	changed	O	O
the	the	O	O
expression	expression	O	O
level	level	O	O
of	of	O	O
five	five	O	O
proteins	proteins	O	O
:	:	O	O
alphabeta-crystalin	alphabeta-crystalin	O	O
,	,	O	O
gamma-enolase	gamma-enolase	S_chemical	O
,	,	O	O
guanidoacetate	guanidoacetate	B_chemical	O
methyltransferase	methyltransferase	I_chemical	O
,	,	O	O
vinculin	vinculin	S_chemical	O
,	,	O	O
and	and	O	O
proteasome	proteasome	O	O
alpha-2	alpha-2	O	O
subunit	subunit	O	O
.	.	O	O

Complementary	complementary	O	O
techniques	techniques	O	O
such	such	O	O
as	as	O	O
western	western	O	O
immunoblotting	immunoblotting	O	O
and	and	O	O
immunohistochemistry	immunohistochemistry	O	O
were	were	O	O
performed	performed	O	O
to	to	O	O
investigate	investigate	O	O
the	the	O	O
validity	validity	O	O
of	of	O	O
the	the	O	O
data	data	O	O
obtained	obtained	O	O
using	using	O	O
the	the	O	O
proteomic	proteomic	O	O
approach	approach	O	O
.	.	O	O

In	in	O	O
conclusion	conclusion	O	O
,	,	O	O
this	this	O	O
study	study	O	O
provides	provides	O	O
new	new	O	O
insights	insights	O	O
into	into	O	O
the	the	O	O
protein	protein	O	O
changes	changes	O	O
occurring	occurring	O	O
in	in	O	O
LID	lid	O	S_disease
.	.	O	O

